Allergy – Page 2 – PossibleThreat Articles

African American children respond differently to asthma medications

September 27, 2019 0 Comments Allergy, Asthma, Chronic Illness, Diseases and Conditions, Mental Health Research, Multiple Sclerosis Research, Personalized Medicine, Sickle Cell Anemia

African Americans suffer asthma more often and more severely than Caucasian patients. However, clinical trials that have shaped treatment guidelines have included few African Americans. A new report demonstrates a shortcoming of that history. Researchers report that African American children respond differently than African American adults and Caucasian adults and children to step-up therapies for inadequately controlled asthma.

News Science

New yardstick offers diagnostic and treatment guidance for idiopathic anaphylaxis

September 18, 2019 0 Comments Allergy, Asthma, Birth Defects, Diseases and Conditions, Patient Education and Counseling, Personalized Medicine, Pharmacology, Today's Healthcare

The new 'Idiopathic Anaphylaxis Yardstick' will help physicians who might be searching for guidance on next steps after their patient has an anaphylactic reaction of an unknown origin.

News Science

Climate change expected to accelerate spread of sometimes-fatal fungal infection

September 16, 2019 0 Comments Allergy, Dengue Fever, Ebola, Fungus, Nature, Soil Types, Virology, Viruses

Valley fever is endemic to hot and dry regions like the southwestern United States and California's San Joaquin Valley, but a new study predicts climate change will cause the fungal infection's range to more than double in size this century, reaching previously unaffected areas across the western U.S.

News Science

Few people with peanut allergy tolerate peanut after stopping oral immunotherapy

September 13, 2019 0 Comments Agriculture and Food, Allergy, Biotechnology, Dentistry, Foodborne Illness, Genetics, Molecular Biology, Staying Healthy

Studies have shown that peanut oral immunotherapy (OIT) — ingesting small, controlled amounts of peanut protein — can desensitize adults and children and prevent allergic reactions, but the optimal duration and dose is unknown. In a study that followed participants after successful OIT, discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects. The study also found that blood tests administered before OIT could predict the success of therapy.